海外の治験の状況「%25E8%2584%25B3%25E5%258D%2592%25E4%25B8%25AD」での検索結果
1件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A 24 week, MRI based, double-blind, randomised, placebo-controlled, modified dose-escalation trial to evaluate the safety, efficacy and pharmacokinetics of BIRT 2584 XX tablets at doses of 100, 300 and 500 mg administered once daily in patients with relapsing forms of Multiple Sclerosis.
- Relapsing forms of Multiple Sclerosis MedDRA version: 8.1 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis
- Czech Republic, Italy, Netherlands
- 2006-07-05
- 1